Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTELLIGENT BIO SOLUTIONS INC. Director's Dealing 2021

Jan 21, 2021

35195_dirs_2021-01-21_a52bfc7b-de2f-4ed4-9062-2c8eef904001.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2021-01-18

Reporting Person: Life Science Biosensor Diagnostics Pty Ltd (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-18 Common Stock X 117647 Acquired 5786694 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-18 Series B Warrants $ X 117647 Disposed Common Stock (117647) Direct

Footnotes

F1: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date.